论文部分内容阅读
在最近的美国临床肿瘤学(ASCO)会上发表的研究证实,他汀类降脂药有潜在的降低结肠直肠癌风险的作用。在这个研究中,他汀类药物使患结肠直肠癌的风险降低51%(比值比为0.49)。
Studies published at the recent American Society of Clinical Oncology (ASCO) confirm that statin lipid-lowering drugs have the potential to reduce the risk of colorectal cancer. In this study, statins reduced the risk of colorectal cancer by 51% (odds ratio, 0.49).